BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36624483)

  • 1. Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
    Meixner E; Wark A; Forster T; Weykamp F; Lang K; König L; Lindel K; Oelmann-Avendano JT; Krisam J; Schneeweiss A; Ellerbrock M; Mielke T; Hörner-Rieber J; Herfarth K; Debus J; Arians N
    Radiat Oncol; 2023 Jan; 18(1):5. PubMed ID: 36624483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.
    Arians N; Lindel K; Krisam J; Herfarth K; Krug D; Akbaba S; Oelmann-Avendano J; Debus J
    Radiat Oncol; 2017 Nov; 12(1):188. PubMed ID: 29179751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
    Arians N; Lindel K; Krisam J; Oelmann-Avendano JT; Meixner E; König L; Hoerner-Rieber J; Wark A; Forster T; Weykamp F; Lang K; Schneeweiss A; Ellerbrock M; Mielke T; Herfarth K; Debus J
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):825-836. PubMed ID: 36642110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study.
    Forsse D; Barbero ML; Werner HMJ; Woie K; Nordskar N; Berge Nilsen E; Ellstrøm Engh M; Vistad I; Rege A; Sævik-Lode M; Andreasen S; Haldorsen IS; Trovik J; Krakstad C
    Am J Obstet Gynecol; 2022 Jan; 226(1):90.e1-90.e20. PubMed ID: 34400137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective assessment of quality of life and psychological distress in patients with gynecologic malignancy: a 1-year prospective study.
    Yavas G; Dogan NU; Yavas C; Benzer N; Yuce D; Celik C
    Int J Gynecol Cancer; 2012 Jul; 22(6):1096-101. PubMed ID: 22672986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; Nijman HW; van de Poll-Franse LV; Creutzberg CL
    Eur J Cancer; 2012 Jul; 48(11):1638-48. PubMed ID: 22176868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: A 2 years prospective single-center study.
    Yavas G; Yavas C; Dogan NU; Ilhan TT; Dogan S; Karabagli P; Ata O; Yuce E; Celik C
    J Cancer Res Ther; 2017; 13(3):524-532. PubMed ID: 28862221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients treated by adjuvant radiotherapy for endometrial and cervical cancers: correlation with dose-volume parameters.
    Pisani C; Deantonio L; Surico D; Brambilla M; Galla A; Ferrara E; Masini L; Gambaro G; Surico N; Krengli M
    Clin Transl Oncol; 2016 Sep; 18(9):901-8. PubMed ID: 26607932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.
    Post CCB; de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger NPB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Kitchener HC; Nijman HW; Lutgens LCHW; Brooks S; Jürgenliemk-Schulz IM; Feeney A; Goss G; Fossati R; Ghatage P; Leary A; Do V; Lissoni AA; McCormack M; Nout RA; Verhoeven-Adema KW; Smit VTHBM; Putter H; Creutzberg CL
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):975-986. PubMed ID: 33129910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study.
    Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
    JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.
    Leung E; Gladwish AP; Davidson M; Taggar A; Velker V; Barnes E; Mendez L; Donovan E; Gien LT; Covens A; Vicus D; Kupets R; MacKay H; Han K; Cheung P; Zhang L; Loblaw A; D'Souza DP
    JAMA Oncol; 2022 Jun; 8(6):1-9. PubMed ID: 35420695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial].
    Zhou Y; Huang H; Wan T; Feng YL; Liu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):962-968. PubMed ID: 34823296
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer.
    Heijkoop ST; Nout RA; Quint S; Mens JWM; Heijmen BJM; Hoogeman MS
    Gynecol Oncol; 2017 Nov; 147(2):439-449. PubMed ID: 28830646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
    Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
    BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.
    Sorbe BG; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Gynecol Cancer; 2012 Sep; 22(7):1281-8. PubMed ID: 22864336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study.
    Ferrandina G; Petrillo M; Mantegna G; Fuoco G; Terzano S; Venditti L; Marcellusi A; De Vincenzo R; Scambia G
    Gynecol Oncol; 2014 Jun; 133(3):518-25. PubMed ID: 24637198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analysis of the impact of adjuvant treatment with external beam radiation therapy and vaginal brachytherapy on health-related quality of life in patients with early-stage endometrioid endometrial carcinoma.
    Kluska A; Tomasik B; Moszynska-Zielinska M; Zytko L; Tracz N; Spych M; Fijuth J; Gottwald L
    Ginekol Pol; 2023 Mar; ():. PubMed ID: 36929785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study.
    van de Poll-Franse LV; Pijnenborg JM; Boll D; Vos MC; van den Berg H; Lybeert ML; de Winter K; Kruitwagen RF
    Gynecol Oncol; 2012 Oct; 127(1):153-60. PubMed ID: 22704950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
    Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial.
    Boevé L; Hulshof MCCM; Verhagen PCMS; Twisk JWR; Witjes WPJ; de Vries P; van Moorselaar RJA; van Andel G; Vis AN
    Eur Urol; 2021 Feb; 79(2):188-197. PubMed ID: 32978014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.